Trial intelligence / Profile preview

Antibiotic Duration for Chronic Rhinosinusitis

NCT01825408Phase 4Completed

Sponsor
University of North Carolina at Chapel Hill
Start
Feb 2013
Primary completion
Jun 2014
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of doxycycline, azithromycin, amoxicillin + clavulanate in chronic rhinosinusitis (CRS), sponsored by University of North Carolina at Chapel Hill. Started Feb 2013; status: completed.

02

Drugs

doxycyclineazithromycinamoxicillin + clavulanate
03

Conditions

chronic rhinosinusitis (CRS)

Beyond the preview

Go deeper on NCT01825408.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01825408.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call